<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Aptargroup, Inc. — News on 6ix</title>
<link>https://6ix.com/company/aptargroup-inc</link>
<description>Latest news and press releases for Aptargroup, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 28 May 2026 11:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/aptargroup-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835496d78dffbe2df0e4402.webp</url>
<title>Aptargroup, Inc.</title>
<link>https://6ix.com/company/aptargroup-inc</link>
</image>
<item>
<title>Aptar Pharma Announces New Patent Applications and Preclinical Data Supporting Investigation of Intranasal and Pulmonary GLP-1 Delivery</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-pharma-announces-new-patent-applications-and-preclinical-data-supporting-investigation-of-intranasal-and-pulmonary-glp-1-delivery</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-pharma-announces-new-patent-applications-and-preclinical-data-supporting-investigation-of-intranasal-and-pulmonary-glp-1-delivery</guid>
<pubDate>Thu, 28 May 2026 11:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., May 28, 2026--Aptar Pharma announces patent applications and preclinical data supporting investigational intranasal and pulmonary GLP-1 delivery.</description>
</item>
<item>
<title>Aptar Advances Sustainability Features in Luxury Packaging through Patented Reloadable Airless Innovation with Clarins</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-advances-sustainability-features-in-luxury-packaging-through-patented-reloadable-airless-innovation-with-clarins</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-advances-sustainability-features-in-luxury-packaging-through-patented-reloadable-airless-innovation-with-clarins</guid>
<pubDate>Wed, 06 May 2026 21:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill, May 06, 2026--Aptar Advances Sustainability Features in Luxury Packaging through Patented Reloadable Airless Innovation with Clarins.</description>
</item>
<item>
<title>Aptar Reports First Quarter 2026 Results</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-reports-first-quarter-2026-results</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-reports-first-quarter-2026-results</guid>
<pubDate>Thu, 30 Apr 2026 21:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., April 30, 2026--Aptar Reports First Quarter 2026 Results</description>
</item>
<item>
<title>Aptar Turns Beauty and Personal Care Products Upside Down with Inverted Lidless Dispensing Closures for Clean, Single‑Handed Dispensing</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-turns-beauty-and-personal-care-products-upside-down-with-inverted-lidless-dispensing-closures-for-clean-singlehanded-dispensing</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-turns-beauty-and-personal-care-products-upside-down-with-inverted-lidless-dispensing-closures-for-clean-singlehanded-dispensing</guid>
<pubDate>Mon, 27 Apr 2026 21:09:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., April 27, 2026--Aptar Turns Beauty and Personal Care Products Upside Down with Inverted Lidless Dispensing Closures for Clean, Single Handed Dispensing</description>
</item>
<item>
<title>Aptar Recognized as One of America’s Climate Leaders by USA Today for the Fourth Consecutive Year</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-recognized-as-one-of-americas-climate-leaders-by-usa-today-for-the-fourth-consecutive-year</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-recognized-as-one-of-americas-climate-leaders-by-usa-today-for-the-fourth-consecutive-year</guid>
<pubDate>Wed, 22 Apr 2026 21:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., April 22, 2026--Aptar Recognized as One of America’s Climate Leaders by USA Today for the Fourth Consecutive Year</description>
</item>
<item>
<title>Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-digital-health-partners-with-enable-injections-for-enfuser-companion-digital-solution</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-digital-health-partners-with-enable-injections-for-enfuser-companion-digital-solution</guid>
<pubDate>Wed, 08 Apr 2026 21:00:00 GMT</pubDate>
<description>Digital solution will be designed to help guide users through injection processCINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) -- Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable’s preferred digital health partner for the enFuse® system.</description>
</item>
<item>
<title>Global Cosmetic Dropper Market to Reach USD 1,855.9 Million by 2036 | Asia Pacific Leads Skincare Boom; AptarGroup</title>
<link>https://6ix.com/company/aptargroup-inc/news/global-cosmetic-dropper-market-to-reach-usd-18559-million-by-2036-or-asia-pacific-leads-skincare-boom-aptargroup</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/global-cosmetic-dropper-market-to-reach-usd-18559-million-by-2036-or-asia-pacific-leads-skincare-boom-aptargroup</guid>
<pubDate>Wed, 01 Apr 2026 10:48:00 GMT</pubDate>
<description>Germany’s cosmetic dropper market grows at 4.7% CAGR to 2036, driven by EU regulations, sustainable packaging shifts, and strong dermocosmetic demand. NEWARK</description>
</item>
<item>
<title>Global Pump and Dispenser Market to Reach USD 84.6 Billion by 2036 Led by North America and AptarGroup Inc. Innovation</title>
<link>https://6ix.com/company/aptargroup-inc/news/global-pump-and-dispenser-market-to-reach-usd-846-billion-by-2036-led-by-north-america-and-aptargroup-inc-innovation</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/global-pump-and-dispenser-market-to-reach-usd-846-billion-by-2036-led-by-north-america-and-aptargroup-inc-innovation</guid>
<pubDate>Fri, 27 Mar 2026 08:04:00 GMT</pubDate>
<description>The USA market is growing at a 6.9% CAGR, driven by personal care, pharma demand, e-commerce growth, and innovation in premium, durable dispensing packaging</description>
</item>
<item>
<title>Global Aerosol Valves Market to Reach USD 3.8 Billion by 2036 as Europe Leads and AptarGroup & LINDAL Expand Capacity</title>
<link>https://6ix.com/company/aptargroup-inc/news/global-aerosol-valves-market-to-reach-usd-38-billion-by-2036-as-europe-leads-and-aptargroup-and-lindal-expand-capacity</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/global-aerosol-valves-market-to-reach-usd-38-billion-by-2036-as-europe-leads-and-aptargroup-and-lindal-expand-capacity</guid>
<pubDate>Thu, 26 Mar 2026 05:20:00 GMT</pubDate>
<description>UK aerosol valve market to grow at 3.4% CAGR, driven by strict recycling rules and eco-friendly packaging demand, pushing sustainable valve innovations.</description>
</item>
<item>
<title>Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptars-unidose-powder-nasal-delivery-system-used-in-ena-respiratory-phase-ii-clinical-study-of-investigational-inna051-nasal-spray</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptars-unidose-powder-nasal-delivery-system-used-in-ena-respiratory-phase-ii-clinical-study-of-investigational-inna051-nasal-spray</guid>
<pubDate>Thu, 19 Mar 2026 21:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill,, March 19, 2026--Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray</description>
</item>
<item>
<title>Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-announces-gael-touya-as-its-next-chief-executive-officer-stephan-b-tanda-to-retire-by-the-end-of-the-year</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-announces-gael-touya-as-its-next-chief-executive-officer-stephan-b-tanda-to-retire-by-the-end-of-the-year</guid>
<pubDate>Tue, 17 Mar 2026 21:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., March 17, 2026--Aptar Announces Gael Touya as its Next President and Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year</description>
</item>
<item>
<title>Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptars-intranasal-delivery-system-used-in-phase-ii-clinical-study-for-investigational-spontanr-nasal-spray</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptars-intranasal-delivery-system-used-in-phase-ii-clinical-study-for-investigational-spontanr-nasal-spray</guid>
<pubDate>Mon, 16 Mar 2026 21:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., March 16, 2026--Aptar Pharma’s Intranasal Delivery System Used in Phase II Clinical Study Investigational SPONTAN® Nasal Spray</description>
</item>
<item>
<title>Aptar Reports Fourth Quarter and Annual 2025 Results</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-reports-fourth-quarter-annual-220000455</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-reports-fourth-quarter-annual-220000455</guid>
<pubDate>Thu, 05 Feb 2026 22:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., February 05, 2026--Aptar Reports Fourth Quarter and Annual 2025 Results</description>
</item>
<item>
<title>Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-declares-quarterly-dividend-announces-220000414</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-declares-quarterly-dividend-announces-220000414</guid>
<pubDate>Thu, 22 Jan 2026 22:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., January 22, 2026--Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details</description>
</item>
<item>
<title>Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-again-recognized-prestigious-score-220000289</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-again-recognized-prestigious-score-220000289</guid>
<pubDate>Wed, 21 Jan 2026 22:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., January 21, 2026--Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment</description>
</item>
<item>
<title>Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-nasal-vaccine-delivery-solutions-220000735</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-nasal-vaccine-delivery-solutions-220000735</guid>
<pubDate>Tue, 13 Jan 2026 22:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., January 13, 2026--Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate</description>
</item>
<item>
<title>Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-eye-care-solutions-designed-220000891</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-eye-care-solutions-designed-220000891</guid>
<pubDate>Mon, 12 Jan 2026 22:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., January 12, 2026--Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™</description>
</item>
<item>
<title>Aptar Announces 2026 Quarterly Conference Call Dates</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-announces-2026-quarterly-conference-220000028</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-announces-2026-quarterly-conference-220000028</guid>
<pubDate>Wed, 07 Jan 2026 22:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., January 07, 2026--Aptar Announces 2026 Quarterly Conference Call Dates</description>
</item>
<item>
<title>Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-digital-health-ura-collaborate-220000917</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-digital-health-ura-collaborate-220000917</guid>
<pubDate>Tue, 06 Jan 2026 22:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., January 06, 2026--Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring</description>
</item>
<item>
<title>Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026</title>
<link>https://6ix.com/company/aptargroup-inc/news/aptar-present-44th-annual-j-220000364</link>
<guid isPermaLink="true">https://6ix.com/company/aptargroup-inc/news/aptar-present-44th-annual-j-220000364</guid>
<pubDate>Mon, 05 Jan 2026 22:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., January 05, 2026--Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026</description>
</item>
</channel>
</rss>